Insulet
PODD
#1556
Rank
C$19.60 B
Marketcap
C$278.46
Share price
1.12%
Change (1 day)
-15.63%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): C$0.55 Billion

According to Insulet's latest financial reports the company's current earnings are C$2.70 Billion. , an increase over its 2024 earnings that were of C$0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 C$0.54 B16.27%
2024 C$0.46 B36.76%
2023 C$0.34 B481.9%
2022 C$58.9 M-45.24%
2021 C$0.10 B43.35%
2020 C$75.03 M18.51%
2019 C$63.31 M41.16%
2018 C$44.85 M-711.95%
2017 -C$7.34 Million-56.85%
2016 -C$16.99 Million-79.31%
2015 -C$82.13 Million63.85%
2014 -C$50.13 Million31.04%
2013 -C$38.25 Million-21.96%
2012 -C$49.02 Million
2010 -C$46.75 Million-42.38%
2009 -C$81.14 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$73.6 Million209.75%
2006 -C$23.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$45.85 B 8,313.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.57 B 2,022.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$8.57 B 1,473.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$35.16 B 6,352.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$0.29 Billion-151.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
C$0.13 B-75.50%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$1.51 B 177.51%๐Ÿ‡บ๐Ÿ‡ธ USA